Eosinophilic esophagitis drives tissue fibroblast regenerative programs toward pathologic dysfunction
Medet Jumabay(University of California San Diego), Seema S. Aceves(Rady Children's Hospital-San Diego), Edsel M. Abud(Scripps Health), Dana Frederick(Arkansas Children's Hospital), Ranjan Dohil, Yanfang Peipei Zhu(University of California San Diego), Austin W.T. Chiang(Foundation Center), Joshua B. Wechsler(Lurie Children's Hospital), Ferhat Ay(La Jolla Institute for Immunology), Michael Croft(La Jolla Institute for Immunology), Richard C. Kurten(University of Arkansas for Medical Sciences), Joshua L. Kennedy(Arkansas Children's Hospital), Nathan E. Lewis(University of Georgia), Mario C. Manresa(University College Dublin), Ben A. Croker(Boston Children's Hospital), Paramita Dutta(La Jolla Institute for Immunology), Haining Li(Scripps Health), Kevin Okamoto(University of California, San Diego)
Cited by 7
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0
|Nature Protocols|2011|1.9k
Deciphering cell–cell interactions and communication from gene expression
|Nature Reviews Genetics|2020|1.3k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
BiGG Models: A platform for integrating, standardizing and sharing genome-scale models
|Nucleic Acids Research|2015|1k